Harvard University Center for the Environment, Cambridge, Massachusetts, United States of America.
PLoS One. 2012;7(7):e41221. doi: 10.1371/journal.pone.0041221. Epub 2012 Jul 27.
Botanical diversity provides value to humans through carbon sequestration, air and water purification, and the provisioning of wild foods and ethnomedicines. Here we calculate the value of botanical ethnomedicines in a rainforest region of Madagascar, the Makira Protected Area, using a substitution method that combines replacement costs and choice modeling. The Makira watershed may comprise approximately 0.8% of global botanical diversity and possesses enormous value both in its ability to provision botanical ethnomedicines to local people and as a source of potentially novel pharmaceutical drugs for society as a whole. Approximately 241 locally-recognized species are used as ethnomedicines, including 113 agricultural or weed species. We equated each ethnomedicinal treatment to the monetary value of a comparable pharmaceutical treatment adjusted by personal preferences in perceived efficacy (rather than from known or assumed medicinal equivalency). The benefit value of these botanical ethnomedicines per individual is $5.40-7.90 per year when using the value of highly subsidized Malagasy pharmaceuticals and $100.60-287.40 when using the value of American pharmaceuticals. Using local pharmaceuticals as substitutes, the value per household is $30.24-44.30 per year, equivalent to 43-63% of median annual household income, demonstrating their local importance. Using the value of American pharmaceuticals, the amount is equivalent to 22-63% of the median annual health care expenditures for American adults under 45 in 2006. The potential for developing novel biomedicines from the Makira watershed's unique flora ranges in untapped benefit value from $0.3-5.7 billion for American pharmaceutical companies, non-inclusive of the importance of providing novel medicines and improved healthcare to society. This study provides evidence of the tremendous current local and prospective global value of botanical ethnomedicines and furthers arguments for the conservation of tropical forests for sustainable use.
植物多样性通过碳固存、空气和水的净化以及野生食物和民族医学的供应为人类提供价值。在这里,我们使用替代方法,结合替代成本和选择模型,计算马达加斯加马基拉保护区热带雨林地区植物民族医学的价值。马基拉流域可能占全球植物多样性的 0.8%左右,它不仅能够为当地人民提供植物民族医学资源,而且作为整个社会潜在新型药物的来源,具有巨大的价值。大约有 241 种被当地认可的物种被用作民族医学,包括 113 种农业或杂草物种。我们将每种民族医学治疗方法等同于具有可比药物治疗方法的货币价值,该价值通过个人对疗效的偏好进行调整(而不是通过已知或假定的药用等效性)。当使用高度补贴的马达加斯加药物的价值时,这些植物民族医学对每个人的效益价值为每年 5.40-7.90 美元,当使用美国药物的价值时,价值为每年 100.60-287.40 美元。使用当地药物作为替代品,每个家庭的价值为每年 30.24-44.30 美元,相当于中等家庭年收入的 43-63%,这表明了它们在当地的重要性。使用美国药物的价值,相当于 2006 年美国 45 岁以下成年人年均医疗保健支出中位数的 22-63%。从马基拉流域独特的植物群中开发新型生物医学的潜力,对于美国制药公司而言,未开发的效益价值从 30 亿美元到 57 亿美元不等,不包括为社会提供新型药物和改善医疗保健的重要性。本研究为植物民族医学当前的巨大本地和预期的全球价值提供了证据,并进一步支持了为可持续利用而保护热带森林的论点。